Valeria Ricotti | Emerging Technologies Shaping Longevity | Milan Longevity Summit 2026

*Redefining ALS and Neurodegenerative Diseases: From Systems Biology to Transformative Therapeutics* What if treating neurodegenerative disease requires us to stop looking at one biological target at a time? In this session from *Emerging Technologies Shaping Longevity* at the *Milan Longevity Summit 2026*, *Dr. Valeria Ricotti* explores how systems biology is changing the way researchers understand ALS and other complex neurodegenerative diseases. Rather than viewing disease as the result of a single malfunctioning pathway, systems biology examines the interactions between genes, cells, tissues, metabolism, immunity, and other biological networks. This broader perspective can reveal patterns that traditional approaches may miss and identify new opportunities for therapeutic intervention. Dr. Ricotti examines how these insights can be translated into transformative therapeutics, offering a new framework for tackling some of medicine's most challenging neurological diseases. Dr. Valeria Ricotti is Co-Founder and Chief Medical Officer of *Vesalius Therapeutics*, where her work focuses on translating systems biology into new approaches for complex diseases. A physician-scientist with expertise in neuromuscular and neurodegenerative disorders, she works at the intersection of clinical medicine, drug development, and biotechnology. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. *Learn more about the Milan Longevity Summit:* https://www.milanlongevitysummit.org/it/speakers26/valeria-ricotti #MilanLongevitySummit #Longevity #OneHealth #ValeriaRicotti #ALS #Neurodegeneration #SystemsBiology #Biotechnology #Neuroscience #FutureOfMedicine